Kyungeun Kim

Kyungeun Kim

Auto-generated profile, based on publicly available information

Kyungeun Kim

Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TVTrinh Thi Le Vuong
Trinh Thi Le Vuong
BSBoram Song
Boram Song
JKJin T. Kwak
Jin T. Kwak
KKKyungeun Kim
Kyungeun Kim
Epstein-Barr virus (EBV), a member of the Herpesviridae family, is associated with lymphoid malignant neoplasms and epithelial carcinogenesis, including gastric cancer (GC).1 Though EBV-associated GC (EBV-GC) accounts for approximately 9% of all GCs,2-4 EBV-GC is 1 of the 4 major molecular subtypes of GC and shows clinical characteristics distinct from non–EBV-GC, such as a higher incidence in men and in the proximal location of the stomach, a lower incidence of lymph node metastasis, and a better prognosis.2-11 It recently has been established that programmed cell death 1 ligand 1 expression is high in EBV-GC, 1 of the target cancers for immune checkpoint inhibitor therapy, along with microsatellite instability (MSI)–high GC.12

25 August 2023 in Medical Image Analysis
Verified
Journal Article
Open access
SASyed Farhan Abbas
Syed Farhan Abbas
TVTrinh Thi Le Vuong
Trinh Thi Le Vuong
KKKyungeun Kim
Kyungeun Kim
BSBoram Song
Boram Song
JKJin Tae Kwak
Jin Tae Kwak
In pathology, cancer grading is crucial for patient management and treatment. Recent deep learning methods, based upon convolutional neural networks (CNNs), have shown great potential for automated and accurate cancer diagnosis. However, these do not explicitly utilize tissue/cellular composition, and thus difficult to incorporate the existing knowledge of cancer pathology. In this study, we propose a multi-cell type and multi-level graph aggregation network (MMGA-Net) for cancer grading. Given a pathology image, MMGA-Net constructs multiple cell graphs at multiple levels to represent intra- and inter-cell type relationships and to incorporate global and local cell-to-cell interactions. In addition, it extracts tissue contextual information using a CNN. Then, the tissue and cellular information are fused to predict a cancer grade. The experimental results on two types of cancer datasets demonstrate the effectiveness of MMGA-Net, outperforming other competing models. The results also suggest that the information fusion of multiple cell types and multiple levels via graphs is critical for improved pathology image analysis.

3 November 2021 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
KCKyungseek Chang
Kyungseek Chang
BSBoram Song
Boram Song
IDIn-Gu Do
In-Gu Do
DKDong-Hoe Koo
Dong-Hoe Koo
HLHyoun Wook Lee
Hyoun Wook Lee
KKKyungeun Kim
Kyungeun Kim
Background/Aim: Lymph node metastasis is an important prognostic factor in gastric cancer patients. In node-negative (N0) gastric cancer patients, additional prognostic factors are needed to reinforce TNM staging. Patients and Methods: We semi-quantitatively recorded the presence of lymphatic, venous, and perineural invasion and evaluated the possibility that they could be used as upstaging factors in N0 gastric cancer by comparing N0 gastric cancer cases with N1 cases. Results: Venous (p<0.001) and perineural (p<0.001) invasion were important factors in the relapse-free survival of N0 patients, but lymphatic invasion was not. N0 cases with venous or perineural invasion had survival curves similar to those of N1 patients. In addition, the number of invasive features (lymphatic, venous, or perineural) was an important factor in predicting poor patient survival. Conclusion: Venous and perineural invasion were significant prognostic factors in N0 gastric cancer cases. It is necessary to record lymphatic, venous, and perineural invasion separately in the pathology report, especially in cases of N0 gastric cancer.

1 September 2023
Verified
Journal Article
Closed access
YCYumin Chung
Yumin Chung
HLHyoun Wook Lee
Hyoun Wook Lee
JPJung Ho Park
Jung Ho Park
CYChang Hak Yoo
Chang Hak Yoo
BSByung Ho Son
Byung Ho Son
KKKyungeun Kim
Kyungeun Kim

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YJYoon Suk Jung
Yoon Suk Jung
Hyuk LeeHyuk Lee
Hyuk Lee
KKKyungeun Kim
Kyungeun Kim
JSJin Hee Sohn
Jin Hee Sohn
HKHong Joo Kim
Hong Joo Kim
JPJung Ho Park
Jung Ho Park
Jung YS, et al. J Korean Med Sci. 2016 Nov;31(11):1768-1774. https://doi.org/10.3346/jkms.2016.31.11.1768

9 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HLHyoun Wook Lee
Hyoun Wook Lee
BSBoram Song
Boram Song
KKKyungneun Kim
Kyungneun Kim
Background/Aim: Colorectal cancer is well known for its “adenoma-carcinoma” sequential carcinogenesis. Some colorectal cancers demonstrate a residual adenoma component during progression from adenoma to invasive carcinoma. However, the clinicopathological significance of residual adenoma component remains unclear. In this study, we aimed to investigate the clinicopathologic and molecular characteristics including the KRAS mutation in colorectal cancers containing a residual adenoma component. Materials and methods: In this study, 498 surgically resected colorectal cancer patients were enrolled. Their detailed clinicopathologic features and results of molecular study including KRAS mutation test and microsatellite instability were analyzed. Results: A residual adenoma component was identified in 42 (8.4%) patients with colorectal cancer. The presence of a residual adenoma component was associated with a high frequency of the KRAS mutation (65%, p = 0.031) as well as indolent clinicopathological features, including polypoid gross type (p < 0.001), well-differentiated histology (p < 0.001), low pT (p < 0.001) and pN stage (p = 0.003), absence of vascular invasion (p = 0.005), and a better progression-free prognosis (p = 0.029). The cases with an adenoma component had a 35.7% discordance rate on the KRAS mutation tests in their adenoma and carcinoma regions. Conclusion: In conclusion, colorectal cancer with a residual adenoma component showed indolent clinicopathologic features and frequent KRAS mutations. Due to the discordance in the incidence of the KRAS mutation between the adenoma and carcinoma components, the adenoma component should be documented in the pathology report, and care should be taken not to include the adenoma component when collecting samples for molecular testing.